Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Will Maintain Rx Headcount Through 2004 Under Cost-Cutting Plan

Executive Summary

Johnson & Johnson expects its pharmaceutical employee headcount to remain constant in 2004

You may also be interested in...



J&J Headcount Reduction Program On Target; Company Posts Strong Quarter

Johnson & Johnson's headcount reduction program is on target, with 1,000 employees taking advantage of an early retirement option, CFO Robert Darretta said on an April 13 conference call

J&J Headcount Reduction Program On Target; Company Posts Strong Quarter

Johnson & Johnson's headcount reduction program is on target, with 1,000 employees taking advantage of an early retirement option, CFO Robert Darretta said on an April 13 conference call

J&J Focusing On “Product Solutions”; Diabetes Care May Be Early Model

Johnson & Johnson is moving towards a business model focused on offering "product solutions" for the health care system, Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia

Related Content

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel